| Serial Number | 76544846 |
| Word Mark | M MERRIMACK PHARMACEUTICALS |
| Filing Date | Friday, September 12, 2003 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, November 12, 2021 |
| Registration Number | 3004786 |
| Registration Date | Tuesday, October 4, 2005 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 20, 2004 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "PHARMACEUTICALS" |
| Description of Mark | The mark contains a stylized depiction of the letter "M." |
| Goods and Services | Scientific, biotechnology, and pharmaceutical product research and development services, namely, drug design, drug research, and development services, featuring, assay development, compound screening, compound, chemical, and drug identification and characterization; computer aided drug design services for others |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 12, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, September 3, 2004 |
| First Use In Commerce Date | Friday, September 3, 2004 |
| Party Name | Merrimack Pharmaceuticals, Inc. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge02139, MA 02139 |
| Party Name | Merrimack Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Merrimack Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Merrimack Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Friday, November 12, 2021 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
| Saturday, April 21, 2012 | POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED |
| Thursday, April 19, 2012 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, April 3, 2012 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, April 2, 2012 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 2, 2012 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, October 26, 2011 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Wednesday, October 26, 2011 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Tuesday, October 25, 2011 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, October 19, 2011 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, October 4, 2011 | TEAS SECTION 8 & 15 RECEIVED |
| Tuesday, October 4, 2005 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 23, 2005 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| Tuesday, August 23, 2005 | ASSIGNED TO LIE |
| Friday, August 12, 2005 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, July 29, 2005 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, July 13, 2005 | USE AMENDMENT FILED |
| Wednesday, July 27, 2005 | EXTENSION 2 GRANTED |
| Wednesday, July 13, 2005 | EXTENSION 2 FILED |
| Wednesday, July 13, 2005 | PAPER RECEIVED |
| Thursday, February 10, 2005 | EXTENSION 1 GRANTED |
| Thursday, January 13, 2005 | EXTENSION 1 FILED |
| Thursday, January 13, 2005 | PAPER RECEIVED |
| Tuesday, July 13, 2004 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 20, 2004 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 31, 2004 | NOTICE OF PUBLICATION |
| Wednesday, March 31, 2004 | NOTICE OF PUBLICATION |
| Tuesday, February 10, 2004 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 6, 2004 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 4, 2004 | ASSIGNED TO EXAMINER |